These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4183038)

  • 1. Disodium cromoglycate, an inhibitor of mas cell degranulation and histamine release induced by phospholipase A.
    Orr TS; Cox JS
    Nature; 1969 Jul; 223(5202):197-8. PubMed ID: 4183038
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48-80.
    Orr TS; Hall DE; Gwilliam JM; Cox OS
    Life Sci I; 1971 Jul; 10(14):805-12. PubMed ID: 4106974
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of substance P-induced histamine release from mast cells by 6, 7-dihydro-6, 8, 8, 10-tetramethyl-8H-pyrano-[3, 2-g] chromone-2-carboxylic acid (EAA).
    Tsutsumi K; Nishibori M; Saeki K
    Acta Med Okayama; 1984 Aug; 38(4):367-74. PubMed ID: 6208753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and modes of action of disodium cromoglycate (Lomudal).
    Cox JS; Altounyan RE
    Respiration; 1970; 27():Suppl:292-309. PubMed ID: 4101895
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective effect of disodium cromoglycate on rat peritoneal mast cells.
    Marshall R
    Thorax; 1972 Jan; 27(1):38-43. PubMed ID: 4111718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of disodium cromoglycate and other inhibitors on in vitro anaphylactic histamine release from guinea pig basophil leucocytes.
    Greaves MW
    Int Arch Allergy Appl Immunol; 1969; 36(5):497-505. PubMed ID: 4187085
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent developments concerned with the mode of action of disodium cromoglycate (Intal).
    Cox JS
    Arerugi; 1970 Nov; 19(11):832-5. PubMed ID: 4922991
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of disodium cromoglycate.
    Orr TS
    Acta Allergol; 1977; Suppl 13():9-27. PubMed ID: 75655
    [No Abstract]   [Full Text] [Related]  

  • 9. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.
    Cox JS
    Br J Dis Chest; 1971 Oct; 65(4):189-204. PubMed ID: 4400180
    [No Abstract]   [Full Text] [Related]  

  • 10. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.
    Cox JS
    Nature; 1967 Dec; 216(5122):1328-9. PubMed ID: 6080064
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of disodium cromoglycate on phospholipase A activity. Studies with egg yolk and isolated mast cell systems.
    Hines MC; Moss GF; Cox JS
    Biochem Pharmacol; 1972 Jan; 21(2):171-9. PubMed ID: 4118943
    [No Abstract]   [Full Text] [Related]  

  • 12. The inhibitory mechanism of rebamipide on the mediator release in the guinea pig lung mast cells activated with specific antigen-antibody reactions.
    Ro JY; Kim JY; Kim KH
    Pharmacology; 2001; 63(3):175-84. PubMed ID: 11598424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells.
    Kusner EJ; Dubnick B; Herzig DJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):41-6. PubMed ID: 4119619
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of Reitakutuukitokasin'i on the antigen-antibody reaction in rats investigated by measuring the increase in blood histamine level and the histamine release from peritoneal mast cells].
    Arai K
    Arerugi; 1993 Jan; 42(1):34-41. PubMed ID: 7681279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.
    Cox JS; Orr TS; Pollard MC; Gwilliam J
    Clin Exp Immunol; 1970 Nov; 7(5):745-57. PubMed ID: 4101095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of histamine secretion from rat peritoneal mast cells and rabbit leukocytes by p-bromophenacyl bromide, a phospholipase A2 inhibitor.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):17-24. PubMed ID: 2436269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pyridoxine on histamine liberation and degranulation of rat mast cells].
    Garcia M; González R
    Allergol Immunopathol (Madr); 1979; 7(6):427-32. PubMed ID: 94242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.